Offers an overview of immune-mediated eye disease, summarizing basic immunologic concepts, ocular immune responses and special topics in ocular immunology. This section also covers diagnostic considerations, therapies and complications for uveitis, and reviews noninfectious (autoimmune) and infectious forms of uveitis.



Major Revision

Section 9 of the Academy's Basic and Clinical Science Course™ (BCSC®) begins with an overview of immune-mediated eye disease, summarizing basic immunologic concepts, ocular immune responses and special topics in ocular immunology.

BCSC Section 9 covers diagnostic considerations, therapies and complications for uveitis. This volume reviews noninfectious (autoimmune) and infectious forms of uveitis. A new table summarizes selected systemic immunomodulatory medications used to treat noninfectious uveitis. Additionally, a discussion on nonbacterial causes of infectious uveitis includes a new subsection on SARS-CoV-2 and COVID-19.

Other topics in Section 9 include scleritis, ocular involvement in HIV infection/AIDS, endophthalmitis and masquerade syndromes. The topic on posterior uveitis and panuveitis has been revised to two chapters to make the content more manageable. In addition, a second appendix about antimicrobial agents for intraocular injection is now included.

New photos, Clinical Pearl boxes and other side bars appear throughout the book, presenting information that can be quickly applied to clinical practice. Increase your understanding with 7 videos and 1 interactive activity. Upon completion of Section 9, readers should be able to: Describe the immunologic and infectious mechanisms involved in the development of and complications from uveitis and related conditions, including AIDS Identify general and specific pathophysiologic processes in acute and chronic ocular inflammation that affect the structure and function of the uvea, lens, vitreous, retina, and other adjacent tissues Distinguish infectious from noninfectious uveitic entities State appropriate differential diagnoses for ocular inflammatory disorders and identify systemic associations or implications